Literature DB >> 10960662

Leukocyte recruitment during pulmonary Cryptococcus neoformans infection.

G B Huffnagle1, T R Traynor, R A McDonald, M A Olszewski, D M Lindell, A C Herring, G B Toews.   

Abstract

Leukocyte recruitment to the site of infection by the encapsulated yeast Cryptococcus neoformans is critical for clearance of the infection. We review data from our lab that chemokines, such as the CC chemokines MCP-1 and MIP-1alpha, are important mediators of leukocyte recruitment during C. neoformans infection. In addition, studies in CC chemokine receptor knockout mice have demonstrated that CCR2 and CCR5 are required not only for leukocyte recruitment but also for other aspects of immune response development and innate imunity to C. neoformans.

Entities:  

Mesh:

Substances:

Year:  2000        PMID: 10960662     DOI: 10.1016/s0162-3109(00)00222-8

Source DB:  PubMed          Journal:  Immunopharmacology        ISSN: 0162-3109


  15 in total

1.  Early induction of CCL7 downstream of TLR9 signaling promotes the development of robust immunity to cryptococcal infection.

Authors:  Yafeng Qiu; Stuart Zeltzer; Yanmei Zhang; Fuyuan Wang; Gwo-Hsiao Chen; Jeremy Dayrit; Benjamin J Murdock; Urvashi Bhan; Galen B Toews; John J Osterholzer; Theodore J Standiford; Michal A Olszewski
Journal:  J Immunol       Date:  2012-03-14       Impact factor: 5.422

2.  Functional expression of chemokine receptor CCR5 on CD4(+) T cells during virus-induced central nervous system disease.

Authors:  William G Glass; Thomas E Lane
Journal:  J Virol       Date:  2003-01       Impact factor: 5.103

3.  Phenotypic switching of Cryptococcus neoformans occurs in vivo and influences the outcome of infection.

Authors:  B C Fries; C P Taborda; E Serfass; A Casadevall
Journal:  J Clin Invest       Date:  2001-12       Impact factor: 14.808

Review 4.  Chemokine control of West Nile virus infection.

Authors:  Jean K Lim; Philip M Murphy
Journal:  Exp Cell Res       Date:  2011-03-10       Impact factor: 3.905

5.  Chemokine receptor Ccr2 is critical for monocyte accumulation and survival in West Nile virus encephalitis.

Authors:  Jean K Lim; Christopher J Obara; Aymeric Rivollier; Alexander G Pletnev; Brian L Kelsall; Philip M Murphy
Journal:  J Immunol       Date:  2010-12-03       Impact factor: 5.422

6.  A MyD88-dependent IFNγR-CCR2 signaling circuit is required for mobilization of monocytes and host defense against systemic bacterial challenge.

Authors:  Eric M Pietras; Lloyd S Miller; Carl T Johnson; Ryan M O'Connell; Paul W Dempsey; Genhong Cheng
Journal:  Cell Res       Date:  2011-04-05       Impact factor: 25.617

7.  Virulence factors identified by Cryptococcus neoformans mutant screen differentially modulate lung immune responses and brain dissemination.

Authors:  Xiumiao He; Daniel M Lyons; Dena L Toffaletti; Fuyuan Wang; Yafeng Qiu; Michael J Davis; Daniel L Meister; Jeremy K Dayrit; Anthony Lee; John J Osterholzer; John R Perfect; Michal A Olszewski
Journal:  Am J Pathol       Date:  2012-07-28       Impact factor: 4.307

8.  Enhanced innate immune responsiveness to pulmonary Cryptococcus neoformans infection is associated with resistance to progressive infection.

Authors:  Loïc Guillot; Scott F Carroll; Robert Homer; Salman T Qureshi
Journal:  Infect Immun       Date:  2008-08-04       Impact factor: 3.441

9.  Monocyte chemoattractant protein 1 mediates retinal detachment-induced photoreceptor apoptosis.

Authors:  Toru Nakazawa; Toshio Hisatomi; Chifuyu Nakazawa; Kosuke Noda; Kazuichi Maruyama; Haicheng She; Akihisa Matsubara; Shinsuke Miyahara; Shintaro Nakao; Yuqin Yin; Larry Benowitz; Ali Hafezi-Moghadam; Joan W Miller
Journal:  Proc Natl Acad Sci U S A       Date:  2007-02-06       Impact factor: 11.205

10.  Altered immune response differentially enhances susceptibility to Cryptococcus neoformans and Cryptococcus gattii infection in mice expressing the HIV-1 transgene.

Authors:  Kassandre Leongson; Vincent Cousineau-Côté; Mathieu Goupil; Francine Aumont; Serge Sénéchal; Louis Gaboury; Paul Jolicoeur; James W Kronstad; Louis de Repentigny
Journal:  Infect Immun       Date:  2013-01-22       Impact factor: 3.441

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.